| Patents for C07C 233 - Carboxylic acid amides (28,881) |
|---|
| 03/01/2001 | WO2001014317A1 Nε-LONG CHAIN ACYLLYSINE CRYSTALS, PROCESS FOR PRODUCING THE SAME AND COSMETICS CONTAINING THE SAME |
| 03/01/2001 | WO2001014299A1 Chiral ligands, transition-metal complexes thereof and uses thereof in asymmetric reactions |
| 03/01/2001 | WO2001014288A1 Optically active isocyanurate and optical resolver comprising derivative of the same |
| 03/01/2001 | WO2001013952A1 Preventives/remedies for heart failure |
| 03/01/2001 | WO2000046203A3 G-protein coupled heptahelical receptor binding compounds and methods of use thereof |
| 03/01/2001 | DE19941062A1 Pure methyl 2-acetamido-3-chloropropionate preparation for use as intermediate for hypotensive agent ramipril, from methyl serinate hydrochloride by chlorination, acetylation and purification |
| 03/01/2001 | DE19940641A1 Verfahren zur Herstellung von 4-Acyl-aminosäureestern und N-Acyl-Aminoacetalen A process for the preparation of 4-acyl-amino acid esters and N-acyl-amino acetals |
| 03/01/2001 | CA2382779A1 Chiral ligands, transition-metal complexes thereof and uses thereof in asymmetric reactions |
| 02/28/2001 | EP1078916A1 Process for the preparation of N-acylaminoacid esters and N-acylaminoacetals |
| 02/28/2001 | EP1078261A1 Method for immobilising and/or crystallising biological macromolecules on carbon nanotubes and uses |
| 02/28/2001 | EP1077944A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity |
| 02/28/2001 | EP1077929A1 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
| 02/28/2001 | EP1077928A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2001 | EP1077927A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2001 | EP1077926A1 Propylisopropyl acetic acid and propylisopropyl acetamide stereoisomers, a method for their synthesis and pharmaceutical compositions containing them |
| 02/28/2001 | EP0792255B1 Liquid crystal compounds having perfluoroether terminal portions |
| 02/28/2001 | CN1285820A Metabotropic glutamate receptor antagonists for treating central nervous system disease |
| 02/28/2001 | CN1285818A Compound for antemortem diagnosis of alzheimer's disease and i(IN VIVO) imaging and prevention of amyloid deposition |
| 02/28/2001 | CN1285817A Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same |
| 02/28/2001 | CN1285816A Method for producing N-(3-amino-4-fluorophenyl)-sulphonamides, N-(3-amino-4-fluorophenyl) carboxylic acid amides and N-(3-amino-4-fluorophenyl) carbamates |
| 02/28/2001 | CN1285351A Taxane with alkyl subtituted lateral chain and medicinal composition containing said compound |
| 02/28/2001 | CA2317097A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 02/28/2001 | CA2316748A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 02/27/2001 | US6194614 Process for the preparation of benzothiazolone compounds |
| 02/27/2001 | US6194613 Reacting carboxylic ester and alkanolamine in extruder or intensive mixer by intensive mixing with supply of heat and simultaneous removal of alcohol formed, isolating hydroxyalkylamide |
| 02/27/2001 | US6194448 N, N-disubstituted amides that inhibit the binding of integrins to their receptors |
| 02/27/2001 | CA2101316C Gnrh analogs |
| 02/22/2001 | WO2001012587A1 Aminosalicylclic acid amides and their use for combating organisms that are harmful to plants |
| 02/22/2001 | WO2001012584A2 Pharmaceutical compounds |
| 02/22/2001 | WO2001012186A1 Cell adhesion inhibitors |
| 02/22/2001 | WO2001012154A2 Targeted lipid particles |
| 02/22/2001 | WO2000071500A8 Halogen compounds |
| 02/22/2001 | DE19938737A1 Aminosalicylsäureamide Aminosalicylamides |
| 02/22/2001 | CA2698353A1 Pharmaceutical compounds |
| 02/22/2001 | CA2381409A1 Nitric ester derivatives |
| 02/22/2001 | CA2380817A1 Cell adhesion inhibitors |
| 02/22/2001 | CA2379431A1 Targeted lipid particles |
| 02/21/2001 | EP1077070A2 Oral drug delivery compositions |
| 02/21/2001 | EP1076641A1 Inhibitors of impdh enzyme |
| 02/21/2001 | EP0833815B1 Synthesis of n-acyl-n-alkylcarboxylates |
| 02/21/2001 | CN1284941A Novel antiarrhythmic compounds |
| 02/21/2001 | CN1284878A Drugs augmenting NKT cells |
| 02/20/2001 | US6191309 Using a compound of formula x2 in a solvent selected from an anhydrous halogenated hydrocarbon, a mixture of water and a halogenated hydrocarbon and optionally the compound itself, to give halogenated 2-amino or 2-acetamidotrifluoromethylbenzene |
| 02/20/2001 | US6191301 Protecting the human epidermis or human hair from ultraviolet radiation, both the a and b rays, specifically in the range from 320 to 400 nm; protect other ingredients from decomposition or breakdown by uv radiation; |
| 02/20/2001 | US6191284 Ligands and complexes for enantioselective hydrogenation |
| 02/20/2001 | US6191277 Hydroxypropylamide peptidomimetics as inhibitors of aspartyl proteases |
| 02/20/2001 | US6191171 Para-aminomethylaryl carboxamide derivatives |
| 02/20/2001 | US6191157 Anticholesterol agents; cardiovascular disorders |
| 02/20/2001 | CA2223800C Process for preparing amides of n-alkyl polyhydroxyalkyl amines comprising a process for regenerating a strong base ion exchange resin |
| 02/20/2001 | CA2195005C Multifunctional cross-linking reagents for hemoglobin, and cross-linked hemoglobin conjugates |
| 02/20/2001 | CA2005283C Radiation-sensitive, ethylenically unsaturated, copolymerizable compounds and their preparation |
| 02/15/2001 | WO2001010868A1 Synthesis of substituted pyrazolopyrimidines |
| 02/15/2001 | WO2001010820A1 Process for making salt-free amphoterics with high mono amphopropionate content |
| 02/15/2001 | WO2001010816A2 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 02/15/2001 | WO2001010433A1 Neuropathy improvers containing nitrogenous compounds as the active ingredient |
| 02/15/2001 | WO2001010383A2 Caspase inhibitors and uses thereof |
| 02/15/2001 | WO2000054759A3 Lxr modulators |
| 02/15/2001 | CA2382759A1 Agent for the remedy of neural damage having a nitrogen-containing compound as the active ingredient |
| 02/15/2001 | CA2381524A1 Synthesis of substituted pyrazolopyrimidines |
| 02/14/2001 | EP1075465A1 Arylphenyl-substituted cyclic keto enols |
| 02/14/2001 | EP0777511B1 Fluorochemical foam stabilizers and film formers |
| 02/14/2001 | CN1284057A Adamantane derivatives |
| 02/14/2001 | CN1284056A Anticonvulsant and sentral nervous system-active bis (fluorophenyl) alkylamides |
| 02/13/2001 | US6187954 Amidation by a fluoropolyalkylether substituted with one or more ester end-groups with a primary or secondary amine, under no catalyst |
| 02/13/2001 | US6187938 Transdermal penetration enhancers |
| 02/13/2001 | US6187933 Bind to retinoid receptors; treating skin disorders |
| 02/13/2001 | US6187927 Process for preparing a 2-chloro-5-chloromethyl-thiazole compound |
| 02/13/2001 | US6187821 Such as 2-amino-2-(3-(4-heptylphenyl)propyl)butane-1,4-diol; immunosuppressant; administering to treat or prevent autoimmune diseases and allergies |
| 02/13/2001 | US6187819 Protein kinase C activators and their use in decreasing expression of cell antigens |
| 02/13/2001 | US6187809 Beta-3 adrenaline receptor agonist drugs for the treatment of diabetes, obesity, and hyperlipemia; 2-(n-(2-(dibenzofuran-3-yloxy)ethyl)amino)-1-phenylethanol, for example |
| 02/13/2001 | US6187804 2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1 -hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid, salt or hydrolysable ester thereof for example, dry blended with an alkali metal carbonate or bicarbonate |
| 02/13/2001 | US6187582 Process for producing optically active amines |
| 02/13/2001 | US6187345 Flutamide compositions and preparations |
| 02/13/2001 | CA2170065C Amide-derived bi-aromatic compounds; pharmaceutical and cosmetic compositions containing the same and their uses |
| 02/13/2001 | CA2164905C Light stabilizatiion of sunscreens derived from dibenzoylmethane; light stabilized cosmetic screening compositions thus produced and use thereof |
| 02/13/2001 | CA2012876C Use of 5-methyltetrahydrofolic acid and 5-formyltetrahydrofolic acid in the treatment of organic mental disturbances |
| 02/08/2001 | WO2001009147A1 Novel chiral phosphorus ligands and the use thereof in the production of optically active products |
| 02/08/2001 | WO2001009096A2 Potassium channel openers |
| 02/08/2001 | WO2001009083A1 Production of n-substituted 2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoylamides |
| 02/08/2001 | WO2001009079A1 2-alkyl-5-halogen-pent-4-ene carboxylic acids and their production |
| 02/08/2001 | WO2001009076A2 Retinoids for the treatment of emphysema |
| 02/08/2001 | WO2001008685A1 Acyclic and cyclic amine derivatives |
| 02/08/2001 | WO2001008672A2 Glucamine compounds for treating hepatitis virus infections |
| 02/08/2001 | WO2001008479A2 High selective herbicidal phenoxypropionic acid alkoxycarbonyl anilid compounds and method of preparing thereof |
| 02/08/2001 | WO2000066528A3 Quinones for treatment of diseases |
| 02/08/2001 | WO2000059851A8 Derivatives of venlafaxine and methods of preparing and using the same |
| 02/08/2001 | DE19936473A1 Neue chirale Phosphorliganden und ihre Verwendung in der Herstellung optisch aktiver Produkte New chiral phosphorus ligands and their use in the preparation of optically active products |
| 02/08/2001 | CA2379993A1 Acyclic and cyclic amine derivatives |
| 02/08/2001 | CA2378936A1 Potassium channel openers |
| 02/08/2001 | CA2362785A1 Glucamine compounds for treating hepatitis virus infections |
| 02/07/2001 | EP1074540A1 Process for the recovery of saturated dicarboxylic acids from the ozonolysis of unsaturated fatty acids |
| 02/07/2001 | EP1073668A2 Solution phase biopolymer synthesis |
| 02/07/2001 | EP1073632A1 Substituted benzamides, their production and their use as cysteine protease inhibitors |
| 02/07/2001 | EP1073631A1 New substituted amides, their production and their use |
| 02/07/2001 | EP1073629A1 Anion-complexing compound, method of preparing the same, an ion-selective membrane and a sensor provided with such a compound or membrane |
| 02/07/2001 | EP1073624A1 Aminomethyl-benzoic ester derivatives as tryptase inhibitors |
| 02/07/2001 | EP1073623A1 Substituted amino acids as erythropoietin mimetics |
| 02/07/2001 | EP1073434A1 Ccr-3 receptor antagonists |
| 02/07/2001 | CN1283181A Substituted beta-alanines |
| 02/07/2001 | CN1282733A Process for rectifying recovery of diluted dimethyl formamide liquid generated in synthesizing artificial leather by wet method |